Sawgrass Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,810
Closed -$573K 178
2024
Q3
$573K Hold
4,810
0.06% 120
2024
Q2
$687K Buy
4,810
+1,788
+59% +$237K 0.07% 116
2024
Q1
$388K Buy
3,022
+56
+2% +$6.67K 0.04% 149
2023
Q4
$307K Hold
2,966
0.03% 167
2023
Q3
$270K Buy
+2,966
New +$261K 0.03% 172

Other funds holding NVO

Sawgrass Asset Management's NVO Position: Q4 2024 in Review

Sawgrass Asset Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 4,810 shares — an estimated $573K sold.

Sawgrass Asset Management first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $687K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sawgrass Asset Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Sawgrass Asset Management sold 4,810 Novo Nordisk shares in Q4 2024, an estimated $573K.
  • Sawgrass Asset Management first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • Sawgrass Asset Management's Novo Nordisk position peaked at $687K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sawgrass Asset Management's 13F filing for Q4 2024, filed 29 Jan 2025.